DekaBank Deutsche Girozentrale Reduces Holdings in Afya Limited (NASDAQ:AFYA)

→ He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad)

DekaBank Deutsche Girozentrale reduced its position in shares of Afya Limited (NASDAQ:AFYA - Free Report) by 57.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 117,086 shares of the company's stock after selling 157,364 shares during the period. DekaBank Deutsche Girozentrale owned 0.12% of Afya worth $2,431,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of the company. Quantbot Technologies LP acquired a new position in shares of Afya during the 1st quarter worth approximately $30,000. Lazard Asset Management LLC acquired a new position in shares of Afya during the 1st quarter worth approximately $30,000. Quarry LP acquired a new position in shares of Afya during the 1st quarter worth approximately $29,000. UBS Group AG boosted its holdings in shares of Afya by 48.4% during the 4th quarter. UBS Group AG now owns 3,151 shares of the company's stock worth $49,000 after purchasing an additional 1,027 shares during the last quarter. Finally, Bank of America Corp DE boosted its holdings in shares of Afya by 138.9% during the 4th quarter. Bank of America Corp DE now owns 3,178 shares of the company's stock worth $50,000 after purchasing an additional 1,848 shares during the last quarter. 88.02% of the stock is currently owned by hedge funds and other institutional investors.

Afya Trading Down 3.1 %

NASDAQ:AFYA traded down $0.54 during trading hours on Friday, reaching $16.96. 41,018 shares of the stock were exchanged, compared to its average volume of 150,530. The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 0.45. The business has a 50-day moving average of $19.81 and a two-hundred day moving average of $19.33. Afya Limited has a twelve month low of $10.72 and a twelve month high of $22.48. The company has a market capitalization of $1.59 billion, a price-to-earnings ratio of 19.72, a PEG ratio of 0.54 and a beta of 0.97.


Afya (NASDAQ:AFYA - Get Free Report) last posted its quarterly earnings data on Thursday, March 14th. The company reported $0.34 earnings per share for the quarter, topping analysts' consensus estimates of $0.32 by $0.02. Afya had a return on equity of 15.88% and a net margin of 13.54%. The business had revenue of $147.35 million for the quarter, compared to analyst estimates of $141.83 million. On average, equities analysts predict that Afya Limited will post 1.54 EPS for the current year.

Analyst Ratings Changes

A number of research firms recently commented on AFYA. Morgan Stanley cut Afya from an "overweight" rating to an "equal weight" rating and upped their price objective for the company from $20.50 to $23.00 in a report on Monday, January 22nd. Citigroup began coverage on Afya in a report on Monday, January 29th. They issued a "neutral" rating and a $23.00 price objective on the stock.

Get Our Latest Analysis on Afya

Afya Company Profile

(Free Report)

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.

See Also

Institutional Ownership by Quarter for Afya (NASDAQ:AFYA)

→ The biggest energy story ever? (From Porter & Company) (Ad)

Should you invest $1,000 in Afya right now?

Before you consider Afya, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Afya wasn't on the list.

While Afya currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Featured Articles and Offers

Search Headlines: